AI-Powered Healthcare for NYC Ride-Share Drivers Launched by Akido Labs

Image Credit: Online Marketing | Splash

Akido Labs, a Los Angeles-based healthcare technology firm, has introduced a program to provide medical services to ride-share drivers in New York City. The company is utilizing its artificial intelligence system, ScopeAI, to assist in diagnosing and treating patients. This effort is designed to offer accessible healthcare to drivers, a group often challenged by the demands of their flexible schedules and lack of traditional employee benefits.

Ride-share drivers, typically independent contractors, do not receive perks like paid sick leave, making time away from work for medical care a financial burden. Akido Labs aims to address this by delivering healthcare that accommodates the drivers’ needs, potentially reducing the time and cost associated with seeking treatment through conventional means. The initiative reflects a targeted response to the healthcare access issues faced by gig economy workers.

[Read More: Evo AI Revolutionizes Genomics: Designing Proteins, CRISPR, and Synthetic Genomes]

ScopeAI’s Role in Medical Support

Central to this program is ScopeAI, an AI-powered tool developed by Akido Labs to aid in medical assessments. The system evaluates patients’ symptoms and medical histories to propose possible diagnoses and treatment plans. According to Akido’s official site, ScopeAI is "trained on the world’s most powerful health data corpus and reinforced with real-time doctor feedback", enabling it to generate data-driven recommendations.

Human clinicians play a key role, reviewing ScopeAI’s suggestions and making the final decisions on patient care. This combination of AI and human oversight aims to ensure accuracy and safety, with Akido highlighting its use of multi-layered reviews and clinical guidelines to support the process. The approach positions ScopeAI as a tool to assist, rather than replace, healthcare professionals.

Details on how the service will be delivered—whether through telehealth, mobile units, or other means—have not been fully specified. Observers note that this could influence how healthcare is adapted for gig workers more broadly, a growing segment of the labour market.

[Read More: AI-Driven Argus Glasses Empower the Visually Impaired with Real-Time Assistance]

Broader Context and Considerations

This effort comes amid ongoing discussions about AI’s role in healthcare. Supporters suggest that tools like ScopeAI can improve efficiency and reach underserved groups, while skeptics raise concerns about potential inaccuracies or biases in AI systems.

The initiative also fits into a larger trend of AI adoption in healthcare, as companies explore technology to manage costs and staffing shortages. The global market for AI in healthcare continues to expand, and programs like this one highlight its potential applications.

[Read More: How Generative AI is Transforming Insomnia Management and Sleep Health Solutions]

License This Article

Source: The Wall Street Journal, Akido Labs

$1.00

$2.00

$5.00

$10.00

Custom Amount

Please enter an amount

$

One-Time Donation Monthly Donation Weekly Donation

$0.00 Total per month $1.00

Support us to keep delivering insightful content on AI development. Your contribution fuels our mission to inspire and inform! Support us to keep delivering insightful content on AI development. Your contribution fuels our mission to inspire and inform!